Extended-duration chemoprophylaxis with neuraminidase inhibitors prevents symptomatic influenza

McGeer, Allison
March 2010
ACP Journal Club;3/16/2010, Vol. 152 Issue 3, p2
Academic Journal
The article offers information on a research related to the effectiveness of the chemoprophylaxis with neuraminidase inhibitors (NAIs) in prevention of influenza. NAIs were compared with placebo for prevention of naturally occuring influenza A virus infection. It concluded that NAIs are effective in reducing the risk for symptomatic influenza.


Related Articles

  • ZANAMIVIR IN THE PREVENTION OF INFLUENZA AMONG HEALTHY ADULTS. Bower, Douglas J.; Slawson, James G. // Journal of Family Practice;Oct1999, Vol. 48 Issue 10, p748 

    The article presents information on a study which addressed the efficacy of zanamivir, a neuraminidase inhibitor, as a chemoprophylaxis agent for influenza. In the study, a total of 1107 healthy adults, mainly students and community volunteers aged 18 to 69 years, were recruited from the...

  • Oseltamivir for Flu Prevention. Johnson, Julie M. // Journal of Family Practice;Feb2000, Vol. 49 Issue 2, p183 

    This article discusses a study on the use of selective oral neuraminidase inhibitor oseltamivir to prevent influenza. The study included 1,562 healthy subjects with a mean average age of 35 years and 63% were women. Researchers conducted two identical randomized placebo-controlled double blinded...

  • Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial. Duval, Xavier; van der Werf, Sylvie; Blanchon, Thierry; Mosnier, Anne; Bouscambert-Duchamp, Maude; Tibi, Annick; Enouf, Vincent; Charlois-Ou, Cécile; Vincent, Corine; Andreoletti, Laurent; Tubach, Florence; Lina, Bruno; Mentré, France; Leport, Catherine // PLoS Medicine;Nov2010, Vol. 7 Issue 11, p1 

    Background: Neuraminidase inhibitors are thought to be efficacious in reducing the time to alleviation of symptoms in outpatients with seasonal influenza. The objective of this study was to compare the short-term virological efficacy of oseltamivir-zanamivir combination versus each monotherapy...

  • Short-Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo-Controlled Study. Kaiser, Laurent; Henry, Dan; Flack, Nancy P.; Keene, Oliver; Hayden, Frederick G. // Clinical Infectious Diseases;3/1/2000, Vol. 30 Issue 3, p587 

    Examines the short-term treatment with neuraminidase inhibitor Zanamivir to prevent influenza. Comparison of the effects of intranasal and/or inhaled zanamivir; Efficacy of the short-term treatment with intranasal zanamivir; Effect of inhaled zanamivir treatment on the rate of influenza.

  • The Ambiguity and the Exigency: Clarifying 'Standard of Care' Arguments in International Research. London, Alex John // Journal of Medicine & Philosophy;Aug2000, Vol. 25 Issue 4, p379 

    This paper examines the concept of a 'standard of care' as it has been used in recent arguments over the ethics of international human-subjects research. It argues that this concept is ambiguous along two different axes, with the result that there are at least four possible standard of care...

  • Rimonabant may cause psychiatric adverse events.  // Reactions Weekly;11/24/2007, Issue 1179, p1 

    The article describes the case of four patients who were tested to assess the safety and efficacy of rimonabant, a therapy for weight-loss. The researchers conducted a meta-analysis of four double-blind trials wherein the patients were required to receive rimonabant 20mg a day or placebo for...

  • Inactivated influenza vaccine prevented influenza in healthy adults. Ohmit, S. E.; Victor, J. C.; Rotthoff, J. R. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p60 

    The article presents a study which examines the prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. Two placebo groups were combined for the efficacy analysis. The inactivated influenza vaccine had a higher rate of vaccine efficacy than did placebo for each...

  • Inactivated influenza vaccine prevented influenza in healthy adults: COMMENTARY. Granwehr, Bruno // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p60 

    The article comments on the research conducted by S. E. Ohmit and his colleagues, which addresses the efficacy of intranasal live attenuated and injected inactivated influenza vaccines in a community-based trial. The author stressed that the increased interest in universal influenza vaccination...

  • Review: Vaccination reduces the incidence of serologically confirmed influenza in healthy adults.  // ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p70 

    This article presents a study, which reports that vaccination reduces the incidence of serologically confirmed influenza (SCI) in healthy adults. The study method consisted of quasirandomized or randomized controlled trials that evaluated the effectiveness of influenza vaccines for protection...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics